SDC1 and Miyoshi myopathy: Administration of Selinexor and Remodelin alongside BTZ efficiently induces tumor cell death in MM cell lines, patient CD138+ plasma cells, and mouse xenograft models, suggesting a promising approach for treating relapsed or refractory MM patients.